ARCHIVES

Ibrutinib Produces 68% Overall Response Rate in Phase II Trial

This article is from The Cancer Letter archive.

Vol. 36 No. 1 | January 25, 2013

Download PDF Visit The Full Archive

Related Articles

AACR Reschedules Annual Meeting For July 11-14, in Washington, DC

April 25, 2003

SAIC-Frederick Makes Awards To Proteomics Research Teams.

January 14, 2005

Bailer NEJM “Irresponsible, Purposely Misleading,” Ignored Facts, DeVita Tells NCA

May 23, 1986

Ohio State, Hawaii Name New Center Directors; Berlin Acting Director At Papanicolaou

July 29, 1988

NIH Emerges From Republican Revolution With Another Increase in Appropriations

October 4, 1996

‘Approval to Apply’ For Proton Facility Upgrade Denied

February 24, 1989